1Alice Alessenko,Subroto Chatterjee. Neutral sphingomyelinase: Localization in rat liver nuclei and involvement in regeneration/proliferation[J] 1995,Molecular and Cellular Biochemistry(2):169～174
6Johns DG, Charpie JR, Webb R C, et al. Is ceramide signaling a tatget for vascular therapeutic intervention [ J ]. Curr Pharm Des, 1998,4(6) :481-488.
7Muller K, Dulku S, Hardwick SJ, et al. Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoptein [ J]. Atherosclerosis, 2001,156( 1 ) : 133-144.
8Jordi F, Lees M, Stanley GH. A aimple medthod for the isolation and purification of total lipids animal tissues [ J ]. J Biol Chem, 1956,23(3) :497-509.
9Sudhir M, Scott IS, Micheal J, et al. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase[ J ] . J Biological Chemistry, 1998,273 ( 7 ) :4081-4088.
10Marathe S, Kuriakose G, Williams K, et al. Sphingomyelinase,an enzyme implicated in atherogenesis, is present in atherosclemfic lesions and binds to specific components of the subendothelial extracellular matrix [ J ]. American Heart Association, 1999,19( 11 ) :2648-2658.
